多轮室内滞留喷洒对高传播地区疟疾发病率和血红蛋白水平的影响
该研究基于乌干达东南部农村0.5-10岁儿童动态队列,评估4轮室内滞留喷洒(IRS)对疟疾发病率和血红蛋白的影响。结果显示,喷洒后各年龄组疟疾发病率显著下降,血红蛋白水平显著升高。研究支持在稳定常年传播地区使用IRS快速降低疟疾传播。
要点
- IRS后平均血红蛋白从11.01 g/dL显著升至12.18 g/dL。
- 研究支持在稳定常年传播区使用IRS快速降低疟疾传播。
核心结论
- 多轮室内滞留喷洒可显著降低高传播地区儿童疟疾发病率并提高血红蛋白水平。
研究设计与样本
- 基于乌干达Nagongera动态队列,纳入2011年8月至2017年6月0.5-10岁儿童,分析4轮IRS前后指标。
主要发现
- 平均血红蛋白从11.01 g/dL(IRS前)显著升至12.18 g/dL(IRS后)。
临床怎么用
- 在稳定常年传播地区可将IRS作为快速降低疟疾传播的干预措施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Indoor residual spraying (IRS) is widely used as a vector control measure, although there are conflicting findings of its effectiveness in reducing malaria incidence. The objective of this study was to estimate the effect of multiple IRS rounds on malaria incidence and hemoglobin levels in a cohort of children in rural southeastern Uganda. METHODS: The study was based upon a dynamic cohort of children aged 0.5-10 years enrolled from August 2011 to June 2017 in Nagongera Subcounty. Confirmed malaria infections and hemoglobin levels were recorded over time for each participant. After each of 4 rounds of IRS, malaria incidence, hemoglobin levels, and parasite density were evaluated and compared with pre-IRS levels. Analyses were carried out at the participant level while accounting for repeated measures and clustering by household. RESULTS: Incidence rate ratios comparing post-IRS to pre-IRS incidence rates for age groups 0-3, 3-5, and 5-11 were 0.108 (95% confidence interval [CI], .078-.149), 0.173 (95% CI, .136-.222), and 0.226 (95% CI, .187-.274), respectively. The mean hemoglobin levels significantly increased from 11.01 (pre-IRS) to 12.18 g/dL (post-IRS). CONCLUSIONS: Our study supports the policy recommendation of IRS usage in a stable and perennial transmission area to rapidly reduce malaria transmission.
引用
- Zinszer K, Charland K, Vahey S, et al. The Impact of Multiple Rounds of Indoor Residual Spraying on Malaria Incidence and Hemoglobin Levels in a High-Transmission Setting. J Infect Dis. 2020. PMID: 31599325. doi:10.1093/infdis/jiz453
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。